ACE2, a host-side receptor for SARS-CoV-2, expressed in CD90-positive alveolar epithelial stem-like cells in the pulmonary metastatic niches of patients with high-grade serous ovarian cancer, is essential (Figure 1A and Table 1). This evidence concerns the gene THY1 and ovarian serous adenocarcinoma.